Hatef Massoumi

Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

Cumali Efe, Renumathy Dhanasekaran, Craig Lammert et al. · Hepatology · 2021 · 72 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +14

Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients†

Paul Feuerstadt, Ari Bunim, Heriberto Garcia et al. · Hepatology · 2009 · 66 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +13

Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis

Cumali Efe, Craig Lammert, Koray Taşçılar et al. · Liver International · 2021 · 40 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +11

An Escalating Dose Regimen of Pegylated Interferon and Ribavirin in HCV Cirrhotic Patients Referred for Liver Transplant

Hatef Massoumi, Viktoriya Khaitova, Brent M. Peterson et al. · Transplantation · 2009 · 19 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis

Shalom Frager, James Szymanski, Jonathan M. Schwartz et al. · Hepatology Communications · 2020 · 19 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +15